FDA Drug recall D-1563-2014
MINERAL IV Injection, compounded by Abrams Royal Pharmacy, Inc., Dallas, TX
- FDA Drug
- Class I
- terminated
- Published 2014-09-03
On 2014-09-03 the FDA classified a Class I recall of MINERAL IV Injection, compounded by Abrams Royal Pharmacy, Inc., Dallas, TX by Abrams Royal Pharamacy, citing non-Sterility; analytical results found product to contain Sphingomonas paucimobilis.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1563-2014 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2013-12-19 |
| Published | 2014-09-03 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Abrams Royal Pharamacy |
| Distribution | US |
Product
MINERAL IV Injection, compounded by Abrams Royal Pharmacy, Inc., Dallas, TX
Reason
Non-Sterility; analytical results found product to contain Sphingomonas paucimobilis
Identifiers
| code_info | Lot number 11142013@74 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1563-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.